Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin Cuppen

Showing results (211-220 of 287) with videos related to

Pageof 29
Sort By:
Nature Genetics|September 12, 2024
Five latent factors underlie response to immunotherapyJoseph Usset, Axel Rosendahl Huber, Maria A Andrianova, et al.
Nature Communications|November 8, 2017
Mapping and phasing of structural variation in patient genomes using nanopore sequencingMircea Cretu Stancu, Markus J van Roosmalen, Ivo Renkens, et al.
Cell Reports|June 20, 2020
Patient-Derived Ovarian Cancer Organoids Mimic Clinical Response and Exhibit Heterogeneous Inter- and Intrapatient Drug ResponsesChris Jenske de Witte, Jose Espejo Valle-Inclan, Nizar Hami, et al.
Genome Medicine|January 28, 2017
Molecular dissection of germline chromothripsis in a developmental context using patient-derived iPS cellsSjors Middelkamp, Sebastiaan van Heesch, A Koen Braat, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 9, 2023
Identifying somatic changes in drug transporters using whole genome and transcriptome sequencing data of advanced tumorsWesley S van de Geer, Ron H J Mathijssen, Job van Riet, et al.
Cell|April 10, 2024
A pan-cancer analysis of the microbiome in metastatic cancerThomas W Battaglia, Iris L Mimpen, Joleen J H Traets, et al.
Pigment Cell & Melanoma Research|December 18, 2014
Detailed imaging and genetic analysis reveal a secondary BRAF(L505H) resistance mutation and extensive intrapatient heterogeneity in metastatic BRAF mutant melanoma patients treated with vemurafenibMarlous Hoogstraat, Christa G Gadellaa-van Hooijdonk, Inge Ubink, et al.
Communications Biology|November 19, 2021
Precancerous liver diseases do not cause increased mutagenesis in liver stem cellsLuan Nguyen, Myrthe Jager, Ruby Lieshout, et al.
Cancers|September 9, 2023
Genomic Alterations Associated with Estrogen Receptor Pathway Activity in Metastatic Breast Cancer Have a Differential Impact on Downstream ER SignalingLindsay Angus, Marcel Smid, Saskia M Wilting, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|April 14, 2021
Micro-costing diagnostics in oncology: from single-gene testing to whole- genome sequencingClémence T B Pasmans, Bastiaan B J Tops, Elisabeth M P Steeghs, et al.
Pageof 29

Showing results (211-220 of 287) with videos related to

Sort By:
Pageof 29
Nature Genetics|September 12, 2024
Five latent factors underlie response to immunotherapyJoseph Usset, Axel Rosendahl Huber, Maria A Andrianova, et al.
Nature Communications|November 8, 2017
Mapping and phasing of structural variation in patient genomes using nanopore sequencingMircea Cretu Stancu, Markus J van Roosmalen, Ivo Renkens, et al.
Cell Reports|June 20, 2020
Patient-Derived Ovarian Cancer Organoids Mimic Clinical Response and Exhibit Heterogeneous Inter- and Intrapatient Drug ResponsesChris Jenske de Witte, Jose Espejo Valle-Inclan, Nizar Hami, et al.
Genome Medicine|January 28, 2017
Molecular dissection of germline chromothripsis in a developmental context using patient-derived iPS cellsSjors Middelkamp, Sebastiaan van Heesch, A Koen Braat, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 9, 2023
Identifying somatic changes in drug transporters using whole genome and transcriptome sequencing data of advanced tumorsWesley S van de Geer, Ron H J Mathijssen, Job van Riet, et al.
Cell|April 10, 2024
A pan-cancer analysis of the microbiome in metastatic cancerThomas W Battaglia, Iris L Mimpen, Joleen J H Traets, et al.
Pigment Cell & Melanoma Research|December 18, 2014
Detailed imaging and genetic analysis reveal a secondary BRAF(L505H) resistance mutation and extensive intrapatient heterogeneity in metastatic BRAF mutant melanoma patients treated with vemurafenibMarlous Hoogstraat, Christa G Gadellaa-van Hooijdonk, Inge Ubink, et al.
Communications Biology|November 19, 2021
Precancerous liver diseases do not cause increased mutagenesis in liver stem cellsLuan Nguyen, Myrthe Jager, Ruby Lieshout, et al.
Cancers|September 9, 2023
Genomic Alterations Associated with Estrogen Receptor Pathway Activity in Metastatic Breast Cancer Have a Differential Impact on Downstream ER SignalingLindsay Angus, Marcel Smid, Saskia M Wilting, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|April 14, 2021
Micro-costing diagnostics in oncology: from single-gene testing to whole- genome sequencingClémence T B Pasmans, Bastiaan B J Tops, Elisabeth M P Steeghs, et al.
Pageof 29